Loss of Cannabinoid CB1 Receptors in the Basal Ganglia in the Late Akinetic Phase of Rats with Experimental Huntington's Disease

Author： Lastres-Becker Isabel   Gómez María   de Miguel Rosario   Ramos José A.   Fernández-Ruiz Javier  

Publisher： Springer Publishing Company

ISSN： 1029-8428

Source： Neurotoxicity Research, Vol.4, Iss.7-8, 2002-01, pp. : 601-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Microglial CB 2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

By Palazuelos Javier  

Brain, Vol. 132, Iss. 11, 2009-11 ,pp. : 3152-3164

Oxford University Press

Access to resources Recommend Favorite

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntingtons disease

By Blzquez Cristina  

Brain, Vol. 134, Iss. 1, 2011-01 ,pp. : 119-136

Oxford University Press

Access to resources Recommend Favorite

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease

By Harris Gordon J.   Codori Ann Marie   Lewis Robert F.   Schmidt Eike   Bedi Asheesh  

Brain, Vol. 122, Iss. 9, 1999-09 ,pp. : 1667-1678

Oxford University Press

Access to resources Recommend Favorite

The CB1 Cannabinoid Receptor in the Brain

By Howlett A.C.  

Neurobiology of Disease, Vol. 5, Iss. 6, 1998-12 ,pp. : 405-416

Academic Press

Access to resources Recommend Favorite

Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease

By Piggott M.A.   Owens J.   O'Brien J.   Colloby S.   Fenwick J.   Wyper D.   Jaros E.   Johnson M.   Perry R.H.   Perry E.K.  

Journal of Chemical Neuroanatomy, Vol. 25, Iss. 3, 2003-03 ,pp. : 161-173

Elsevier

Access to resources Recommend Favorite